Refractory Multiple Myeloma

DBCOND0028542Cardiovascular DiseasesHemic and Lymphatic Diseases

Refractory Multiple Myeloma is the indication for 17 drugs in DrugBank. It is covered by 34 curated, structured indications.

Also known as
Multiple Myeloma, Refractory
Classified under
Indicated drugs

What you can answer from here — as of October 07, 2026

17Indicated drugsWith each drug's targets and mechanism
Listed above
34Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
242Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Refractory Multiple Myeloma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In